Cargando…

A case of CRPC with multiple bladder invasions treated with EBRT followed by HDR-BT boost

We report a case of post-operative local recurrence of castration-resistant prostate cancer with multiple bulky bladder invasions treated using external beam radiotherapy (EBRT) followed by a high-dose-rate brachytherapy (HDR-BT) boost. The EBRT dose was 46 Gy delivered in 23 fractions with intensit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takagawa, Yoshiaki, Itami, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Institute of Radiology. 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906154/ https://www.ncbi.nlm.nih.gov/pubmed/35300242 http://dx.doi.org/10.1259/bjrcr.20210039

Ejemplares similares

Cosmetic effect in patients with early breast cancer treated with breast conserving therapy (BCT) and with HDR brachytherapy (HDR-BT) “boost”
por: Kulik, Anna, et al.
Publicado: (2009)

Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer
por: Chicheł, Adam, et al.
Publicado: (2009)

HDR brachytherapy (HDR–BT) combined with stent placement in palliative treatment of esophageal cancer
por: Kanikowski, Marek, et al.
Publicado: (2009)

SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer
por: Takagawa, Yoshiaki, et al.
Publicado: (2022)

Development of an HDR‐BT QA tool for source position verification
por: Kumazaki, Yu, et al.
Publicado: (2020)

Interstitial HDR brachytherapy (HDR-BT) in early stage mobile tongue cancers in young patients – Gliwice experience
por: Kellas-Ślęczka, Sylwia, et al.
Publicado: (2010)

Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high–dose–rate brachytherapy (HDR–BT) as a boost
por: Chicheł, Adam, et al.
Publicado: (2009)

Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer
por: Ecke, Thorsten H., et al.
Publicado: (2016)

High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma – a case report
por: Takagawa, Yoshiaki, et al.
Publicado: (2022)

Comparative analysis of the prognosis of external beam radiation therapy (EBRT) and EBRT plus brachytherapy for glioblastoma multiforme: a SEER population-based study
por: Yang, Kai, et al.
Publicado: (2022)

High‐dose‐rate interstitial brachytherapy for a bulky sebaceous carcinoma of the eyelid: A case report
por: Takagawa, Yoshiaki, et al.
Publicado: (2019)

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost
por: Panettieri, Vanessa, et al.
Publicado: (2020)

Endokavitäre Kontakttherapie vs. EBRT als Boost bei organerhaltender Strahlentherapie von T2–3-Rektumkarzinomen: Ergebnisse der OPERA-Studie
por: von Wieding, Emilie, et al.
Publicado: (2023)

Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2022)

Treatment of early stage vaginal cancer with EBRT and MRI-based intracavitary brachytherapy: A retrospective case review
por: Damast, Shari, et al.
Publicado: (2016)

Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy
por: Kumon, Hiromi, et al.
Publicado: (2015)

Clinical aspects of mCRPC management in patients treated with radium-223
por: Rizzini, Elisa Lodi, et al.
Publicado: (2020)

Comparison of IORT (Radical and Boost Dose) and EBRT in Terms of Disease-Free Survival and Overall Survival according to Demographic, Pathologic, and Biological Factors in Patients with Breast Cancer
por: Hashemi, Solmaz, et al.
Publicado: (2021)

Inferior vena cava syndrome caused by retroperitoneal fibrosis after pelvic irradiation: A case report
por: Murakami, Naoya, et al.
Publicado: (2018)

Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment
por: Koka, Krishna, et al.
Publicado: (2022)

Virtual HDR Boost for Prostate Cancer: Rebooting a Classic Treatment Using Modern Tech
por: Wegener, Eric, et al.
Publicado: (2023)

Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
por: Benkhaled, Sofian, et al.
Publicado: (2023)

Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir
por: Anwar, Mekhail, et al.
Publicado: (2014)

Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer
por: Moll, Matthias, et al.
Publicado: (2021)

ALICE exhibition in HDR
por: Ordan, Julien Marius
Publicado: (2018)

The Realistic HDR Image
por: Cooper, Tim
Publicado: (2014)

A world in HDR
por: Ratcliff, Trey
Publicado: (2010)

MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
por: Kazi, Aleksandra, et al.
Publicado: (2010)

Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT)
por: Joseph, Kurian Jones, et al.
Publicado: (2008)

Quality Assessment of HDR/WCG Images Using HDR Uniform Color Spaces
por: Rousselot, Maxime, et al.
Publicado: (2019)

Systematically understanding the immunity leading to CRPC progression
por: Ji, Zhiwei, et al.
Publicado: (2019)

Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro
por: Gholami, Yaser H., et al.
Publicado: (2018)

Comparative analysis of cancer cell responses to targeted radionuclide therapy (TRT) and external beam radiotherapy (EBRT)
por: Grzmil, Michal, et al.
Publicado: (2022)

TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity
por: d’Abadie, Philippe, et al.
Publicado: (2022)

Evaluation of auto-segmentation for EBRT planning structures using deep learning-based workflow on cervical cancer
por: Wang, Jiahao, et al.
Publicado: (2022)

Simulation of an HDR “Boost” with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study
por: Remick, Jill S., et al.
Publicado: (2020)

HDR photography photo workshop
por: Carr, Pete, et al.
Publicado: (2009)

Methodologies for Improving HDR Efficiency
por: Liu, Mingjie, et al.
Publicado: (2019)

HDR Syndrome Accompanying Type 1 Diabetes Mellitus and Hypopituitarism
por: Can, Mustafa, et al.
Publicado: (2019)

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone
por: Lolli, Cristian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tu2k65uvobpck3uvgmbsqn7444